Prostate cancer is a formidable opponent, but through research and the tireless dedication of experts like Tulane Cancer Center’s Oliver Sartor, M.D., we are battling back, and we are making progress.
One in every nine of our fathers, husbands, brothers or sons will be diagnosed with prostate cancer during his lifetime.
One in 41 will die of this disease.
Since 2010, seven drugs have received FDA approval for the treatment of advanced prostate cancer. Dr. Sartor has been directly involved at a national leadership level – as either principal investigator, co-principal investigator, or chair of the Data Monitoring committee – for five out of the seven. These are the first new treatment options offering hope for men with advanced disease since 2004, and they were only possible through large, multi-institutional clinical research trials. Dr. Sartor is currently leading – as co-principal investigator – another large national trial that might also make a difference.